Meloxicam Bluepharma (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the synthesis of prostaglandins that mediate inflammation, pain and fever. This selective inhibition provides anti‑inflammatory and analgesic effects while sparing COX‑1 activity that protects the gastric lining.

The appropriate dose of meloxicam is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, renal and hepatic function, and other individual factors. Dosage regimens may vary, and patients should follow the specific instructions provided by their healthcare professional.

The safety of meloxicam during pregnancy and lactation has not been definitively established. It is generally classified as contraindicated or used only when the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Meloxicam Bluepharma. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Meloxicam offers a higher degree of COX‑2 selectivity compared with many traditional NSAIDs such as ibuprofen or naproxen, which may translate into a lower risk of gastrointestinal irritation. However, it still carries cardiovascular and renal warnings similar to other NSAIDs, and the choice of agent should be individualized based on patient risk factors.

Store Meloxicam Bluepharma tablets at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture, light and excessive heat. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.

Meloxicam Bluepharma is taken orally, usually with a full glass of water. It may be taken with or without food, but patients who experience stomach upset are advised to take it with meals. Swallow the tablet whole; do not crush or chew it.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe skin reactions (e.g., Stevens‑Johnson syndrome), liver enzyme elevation, and acute kidney injury. Patients should seek immediate medical attention if they notice signs such as black stools, chest pain, sudden rash, jaundice or reduced urine output.

Meloxicam should be avoided in patients with known hypersensitivity to meloxicam or other NSAIDs, active gastrointestinal ulceration or bleeding, severe heart failure, uncontrolled hypertension, advanced renal or hepatic impairment, and in those who are in the third trimester of pregnancy. A thorough medical history is essential before initiating therapy.